132 related articles for article (PubMed ID: 26060394)
21. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Wang TM; Yeung SY; Jeng PY; Liao CH; Lin TY; Lin CC; Lin BR; Jeng JH
Atherosclerosis; 2011 Dec; 219(2):559-65. PubMed ID: 21993412
[TBL] [Abstract][Full Text] [Related]
23. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
[TBL] [Abstract][Full Text] [Related]
24. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
[TBL] [Abstract][Full Text] [Related]
25. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Hayakawa M; Matsumoto M; Sugimoto M; Wada H; Tsubaki K; Fujimura Y
Eur J Pharmacol; 2012 Sep; 691(1-3):151-5. PubMed ID: 22796451
[TBL] [Abstract][Full Text] [Related]
27. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
[TBL] [Abstract][Full Text] [Related]
28. Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs.
Scharbert G; Gebhardt K; Sow Z; Duris M; Deusch E; Kozek-Langenecker S
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):775-80. PubMed ID: 17982319
[TBL] [Abstract][Full Text] [Related]
29. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
30. Statins have an early antiplatelet effect in patients with acute myocardial infarction.
Matetzky S; Fefer P; Shenkman B; Shechter M; Novikov I; Savion N; Varon D; Hod H
Platelets; 2011; 22(2):103-10. PubMed ID: 21171935
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
32. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway.
Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N
J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
36. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human blood.
Hernandez MR; Tonda R; Pino M; Serradell M; Arderiu G; Escolar G
Eur J Clin Invest; 2004 Apr; 34(4):297-302. PubMed ID: 15086362
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet drugs.
De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
[TBL] [Abstract][Full Text] [Related]
39. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
